Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing fenofibrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate adverse reaction |
Causative agent (attribute) |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Allergy to fenofibrate |
Causative agent (attribute) |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronised 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronised 67 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 267 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 134 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate Micro 200mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 67mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 134mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 54 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Product containing fenofibrate micronized |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 107 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronized (substance) |
Is a |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 145 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 48 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate 150 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Cip-fenofibrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Fenofibrate 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Allergy to fenofibrate |
Causative agent (attribute) |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 54 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 54 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 107 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 107 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 145 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 145 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 48 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 48 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate 150 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate 150 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronized (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate 150 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 48 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 54 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing fenofibrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 145 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 107 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing only fenofibrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing only fenofibrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing fenofibrate and rosuvastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate- and rosuvastatin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Product containing only fenofibrate and rosuvastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate and rosuvastatin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
1 |
Fenofibric acid |
Is a |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
|
Atorvastatin- and fenofibrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
2 |
Product containing only atorvastatin and fenofibrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
2 |
Atorvastatin- and fenofibrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
2 |
Atorvastatin and fenofibrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
2 |
Atorvastatin (as atorvastatin calcium) 10 mg and fenofibrate 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
2 |
Atorvastatin (as atorvastatin calcium) 10 mg and fenofibrate 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate (substance) |
Inferred relationship |
Some |
2 |